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Abstract 
We previously identified a benzyloxycarbonyl(Z)-Leu-Leu-Leu-4-methylcoumaryl-7-amide (ZLLL-MCA) degrading activity in proteasome asa 
candidate for the regulator of neurite outgrowth. As its counterpart, we purified a protein from bovine brain that specifically inhibits the ZLLL-MCA 
degrading activity in proteasome. This protein is heat stable and has no effect on the other catalytic activities in proteasome, or on the activities of 
trypsin, chymotrypsin, or m- and p-calpains either. The molar atio ofinhibitor-to-proteasome that inhibits 50% of the ZLLL-MCA degrading activity 
of proteasome is 1:1. The inhibitory mechanism of the inhibitor against proteasome is non-competitive. Finally, the inhibitor was identified as 
heat-shock protein 90 (HSP90) by partial amino acid sequencing and immunodetection. The results uggest that HSP90 initiates neurite outgrowth 
through the inhibition of the ZLLL-MCA degrading activity in proteasome. 
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1. Introduction 
A tr ipept ide aldehyde protease inhibitor, ben- 
zy loxycarbonyl(Z)-Leu-Leu- leucinal  (ZLLLal ) ,  initiates 
neurite outgrowth in PC12 cells at an opt imal  concentra- 
t ion of  30 nM [1]. This result suggests the existence of  a 
protease that regulates neurite format ion in PC12 cells. 
Thus we at tempted to identify this target protease in 
bovine brain using Z-Leu-Leu-Leu-4-methylcoumaryl -7-  
amide (ZLLL -MCA) ,  in which the aldehyde moiety of  
ZLLLa l  was changed to 45-methylcoumaryl -7-amide to 
serve as a substrate for the protease. As a result, we 
purif ied a proteasome with a molecular  mass of  about  
660 kDa as a ZLLL -MCA degrading protease, and sug- 
gested the possibi l i ty that the proteasome is involved in 
the regulat ion of  neurite format ion in PC 12 cells [2]. 
Proteasome, a mult icatalyt ic protease, has been identi- 
fled in many species and plays an essential role in the 
ATP/ubiquit in-dependent pathway [3-5]. It has a high 
molecular  mass (about 700 kDa),  is composed of  13-15 
distinct subunits of  similar size (21-31 kDa),  and con- 
tains three or four different peptidase activities [610].  It 
is believed that proteasome is related to mult iple cellular 
phenomena because it plays an essential role in the ATP! 
ubiquit in-dependent pathway. I f  the ZLLL -MCA de- 
grading activity in proteasome is involved in the regula- 
t ion ofneur i te  format ion in PC12 cells, there should exist 
an endogenous inhibitor that inhibits ZLLL -MCA de- 
grading activity. The fact that the ZLLL -MCA degrad- 
ing activity increased dramat ical ly  dur ing the purifica- 
t ion of  proteasome [2] encouraged us to isolate a specific 
endogenous inhibitor of  a ZLLL -MCA degrading activ- 
ity in proteasome. 
*Corresponding author. Fax: (81) (3) 5685-6609. 
Abbreviations: Z, benzyloxycarbonyl; ZLLLal, benzyloxycarbonyl- 
Leu-Leu-leucinal; MCA, 4-methylcoumaryl-7-amide; ZLLL-MCA, 
benzyloxycarbonyl-Leu-Leu-4-methylcoumaryl-7-amide; SucLLVY- 
MCA, succinyl-Leu-Leu-Val-Tyr-4-methylcoumaryl-7-amide; Boc- 
VLK-MCA, tertiary butyloxycarbonyl-Val-Leu-Lys-4-methylcouma- 
ryl-7-amide; ZLLE-NA, benzyloxycarbonyl-Leu-Leu-Glu-fl-naphthyl- 
amide; buffer A, 20 mM Tris-HCl, pH 7.0, containing 10% glycerol; 
buffer B, 20 mM Tris-HCl, pH 7.5, containing 5 mM EDTA and 10% 
glycerol; PAGE, polyacrylamide g l electrophoresis; PVDF, polyvi- 
nylidene difluoride; HSP, heat-shock protein. 
2. Materials and methods 
2.1. Materials 
Reagents and chemicals were purchased from the following manufac- 
turers: succinyl(Suc)-Leu-Leu-Val-Tyr-MCA (SucLLVY-MCA) and 
tertiary-butyloxycarbonyl(Boc)-Val-Leu-Lys-MCA (BocVLK-MCA) 
from Peptide Institute Inc. (Japan); Z-Leu-Leu-Glu-fl-naphthylamide 
(ZLLE-NA) from Sigma Chemical Co. ZLLL-MCA was synthesized 
according to the azide method [11] and the dicyclohexylcarbodiimide 
method [12]. Proteasome was purified by a previous method [2]. 
2.2. Purification of an endogenous protein inhibitor of proteasome 
In the purification of proteasome asa ZLLL-MCA degrading pro- 
tease from bovine brain, the ZLLL-MCA degrading activity in pro- 
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teasome increased after phenyl-Sepharose column chromatography [2]. 
This result suggests that a specific endogenous protein inhibitor is 
separated from the proteasome fraction after phenyl-Sepharose column 
chromatography. The proteins were separated according to a previous 
procedure [2] up to the phenyl-Sepharose column chromatography step. 
From there, the 50% ethylene glycol eluent was collected and dialyzed 
against buffer A (20 mM Tris-HCl, pH 7.0, containing 10% glycerol). 
The dialyzed material was applied to a Mono Q column (0.5 x 5 cm), 
equilibrated with buffer B (20 mM Tris-HCl, pH 7.5, containing 5 mM 
EDTA and 10% glycerol) containing 0.1 M NaCl, and the adsorbed 
material was eluted with 50 ml of a gradient of 0.1-l M NaCl in buffer 
B. The fractions with inhibitory activity were pooled and dialyzed 
against buffer A. This dialyzed material was used as the purified inhib- 
itor. 
2.3. Electrophoretic techniques 
Electrophoresis under non-denaturating conditions was performed 
in slab gels at a constant (5%) polyacrylamide concentration. The slab 
gels were run in 7 mM Tris-glycine, pH 8.3, at 5 mA for 3 h at room 
temperature. Protein was detected by silver staining. Electrophoresis 
under denaturing conditions in the presence of SDS was performed in 
12.5% polyacrylamide gels [13]. Electrophoresis was performed at 15 
mA for 90 min at room temperature. The gels were stained with 0.1% 
Coomassie brilliant blue-50% methanol-10% acetic acid and destained 
by diffusion in 5% methanol-7.5% acetic acid. 
2.4. Assay for proteasome inhibition 
The fluorescent substrate degrading activities were determined by 
measuring the fluorescence of the liberated fluorescent materials. The 
reaction mixture (1 ml) contained 100 mM Tris-acetate, pH 7, enzyme, 
inhibitor and 25 ,uM substrate dissolved in dimethylsulfoxide. After 
incubation at 37°C for 15 min, the reaction was stopped by adding 10% 
SDS (100 ~1) and 0.1 M Tris-acetate (900 ,~l), pH 9. The fluorescence 
of the reaction products was measured (MCA substrates, excitation 380 
nm/emission 440 nm; NA substrate, excitation 335 nm/emission 410 
nm). 
2.5. Assaysfor the inhibition of trypsin, chymotrypsin, m- andp-calpains 
Trypsin, chymotrypsin, m- andp-calpain activities were measured by 
previously described methods [l&16]. To determine the inhibitory ac- 
tivities of the inhibitor, the inhibitor in various concentrations was 
included in the assay mixtures. 
2.6. Amino acid sequence determination of the endogenous protein 
inhibitor 
After SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of the 
purified inhibitor, the protein was electroblotted onto a polyvinylidene 
difluoride (PVDF) membrane and then the PVDF membrane pieces 
with the protein attached were subjected directly to an Applied Biosys- 
terns 470A sequencer equipped with an on-line 120A PTH analyzer to 
determine the sequence around the N-terminus [17]. To get internal 
sequences, the protein inhibitor in SDS-polyacrylamide gels was di- 
gested by lysylendopeptidase and the peptides were sequenced after 
purification on HPLC [18]. 
3. Results 
3.1. PuriJication of an endogenous protein that 
spec$cally inhibits the ZLLL-MCA degrading 
activity of proteasome 
The elution patterns of the inhibitor from the phenyl- 
Sepharose and Mono Q columns are shown in Figs. 1 
and 2, respectively. As shown in Fig. 1, the inhibitor 
fractions (the bar fractions) were separated from the pro- 
teasome fractions (the fractions eluted with a decreasing 
linear gradient of 1-O M NaCl in buffer B). When the 
dialyzed inhibitor fractions were chromatographed on 
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Fig. 1. Phenyl-Sepharose column chromatography. (m) Inhibitory ac- 
tivity toward ZLLL-MCA degrading proteasome. The fractions (50~1) 
were heated at 70°C for 10 min and added to the assay mixture. The 
released fluorescent reaction products in nmol per 1 h using 2 pg 
proteasome are shown. The bar indicates the fractions pooled. 
the Mono Q column, the inhibitor was eluted at 0.25 M 
NaCl. About 2 mg of the inhibitor was obtained. 
3.2. Electrophoretic properties of the purljied inhibitor 
As shown in Fig. 3A, the purified inhibitor had a 
molecular mass of about 170 kDa on native-PAGE (5% 
polyacrylamide). On SDS-PAGE (12.5% poly- 
acrylamide), the purified inhibitor gave a single protein 
band (about 85 kDa) (Fig. 3B). This result suggests that 
the inhibitor is a homodimer of 85 kDa subunits. 
3.3. Inhibition of proteasome and other proteases by the 
purljied inhibitor 
The effects of the purified inhibitor on the catalytic 
activities in proteasome were examined. As shown in Fig. 
4, the ZLLL-MCA degrading activity in proteasome was 
inhibited strongly, while the well-known SucLLVY- 
MCA (chymotrypsin-like), BocVLK-MCA (trypsin-like) 
and ZLLE-NA (V8 protease-like) degrading activities 
were hardly affected. Fifty percent inhibition of the 
ZLLL-MCA degrading activity was observed at a molar 
ratio of inhibitor-to-proteasome of 1: 1, assuming the 
molecular weights of the inhibitor and proteasome to be 
170 and 660 kDa, respectively. The inhibitor had no 
effect on the activities of trypsin, chymotrypsin, or m- 
and p-calpains, even when present at a lo-fold molar 
excess to these proteases. The inhibitory mechanism of 
the inhibitor against the ZLLL-MCA degrading activity 
in proteasome was determined to be non-competitive by 
Lineweaver-Burk plot analysis (Fig. 5). 
3.4. Amino acid sequence determination of the purified 
inhibitor 
The N-terminal 14 amino acid residues of the inhibitor 
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Fig. 2. Mono Q column chromatography of the protein fraction from phenyl-Sepharose column chromatography. (w) Inhibitory activity towards 
ZLLL-MCA degrading proteasome. The fractions (50 ~1) were heated at 70°C for 10 min and added to the assay mixture. The released fluorescent 
reaction products in nmol per 1 h using 2 pg proteasome are shown. The bar indicates the fractions pooled. 
and 9-13 amino acid residues of six peptides generated 
by lysylendopeptidase digestion were sequenced. This 
analysis showed the inhibitor to be analogous to human 
and murine HSP90. The sequences obtained were com- 
pared with those of HSP90 from human [ 191 and mouse 
[20] (Fig. 6). Homology as high as 94% was observed for 
human HSP90 (alternative name HSP90a); and 92% for 
murine HSP90 (alternative name HSP86). Moreover, the 
inhibitor was positive on immunoblotting using anti-rab- 
bit HSP90 polyclonal antibody (Fig. 7). Its existence as 
a homodimer is also consitent with the characteristics of 
HSP90. Thus, we conclude that the inhibitor is, in fact, 
HSP90. 
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Fig. 3. Native-PAGE (A) and SDS-PAGE (B) of the purified en- 
dogenous inhibitor. Samples containing 1 pg inhibitor were used. Mo- 
lecular mass standards are as indicated: (A) thyroglobulin (669 kDa), 
ferritin (440 kDa), catalase (232 kDa), lactate dehydrogenase (140 kDa) 
and albumin (67 kDa); (B) phosphorylase b (94 kDa), albumin (67 
kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soybean 
trypsin inhibitor (20.1 kDa) and a-lactalbumin (14.4 kDa). 
4. Discussion 
From bovine brain, we purified a protein that specifi- 
cally inhibits the ZLLL-MCA degrading activity in pro- 
teasome. This protein was identified as HSP90 by partial 
amino acid sequencing and immunodetection. Other 
characteristics of the inhibitor support this conclusion. 
Although HSP90 acts as a chaperon, it is suggested 
that the inhibition of the ZLLL-MCA degrading activity 
in proteasome is due to HSP90-proteasome binding, not 
to HSP90-substrate binding. The reasons are (i) HSP90 
Inhibitor @g/ml) 
Fig. 4. The effect of the endogenous inhibitor on proteasome. (c_:) 
ZLLL-MCA degrading activity; (0) SucLLVY-MCA degrading activ- 
ity; (0) BocVLY-MCA degrading activity; (w) ZLLE-NA degrading 
activity. Activity of proteasome (3.3 pug) in the absence of inhibitor was 
considered to be 100%. 
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Fig. 5. Lineweaver-Burk plot analysis of the inhibition of proteasome 
by the endogenous inhibitor. (0) No inhibitor; 0 ‘) 0.46 fig inhibitor/ 
assay; (m) 0.91 pg inhibitor/assay. 
is not separated from proteasome until phenyl-sepha- 
rose column chromatography (data not shown), (ii) 
ZLLL-MCA is added to the reaction mixture in far ex- 
cess to the HSP90, (iii) the inhibitory mechanism of 
HSP90 against proteasome is non-competitive, and (iv) 
other substrate degrading activities in proteasome are 
not inhibited by HSP90. 
In cells, heat-shock proteins (the other name is stress 
proteins) are synthesized in response to various biologi- 
cal stresses such as exposure to non-physiological tem- 
peratures [21,22], drugs [23], amino acid analogs [24], 
and transition metals [25]. Heat-shock proteins are clas- 
sified into four families, namely, HSP90, HSP70, HSP60, 
and low molecular weight heat-shock proteins. Among 
these, HSP90 and HSP70 are the major ones [26,27]. 
HSP90 has a molecular mass of about 90 kDa and 
exists as a dimer [28]. The primary structure of HSP90s 
are highly homologous in many species. It is one of the 
most abundant cellular proteins found even under non- 
stress conditions. It has been found to be associated with 
a number of other intracellular proteins, including actin 
[28,29], pp60”-“‘, pp140fp”, ~~94~“” [30,31], and steroid 
InhIbitor PEETQAQDQPMEEE 
Human (2-15) PEETQTQDQPMEEE 
Mouse (2.15) PEETQTQDQPMEEE 
PeptIde 4 LGIHEXSQNRK 
Human (447-457) LGIHEDSQNRK 
Mouse (448.458) LGIHEDSQNRK 
Peptide 1 ESDDKPEIED 
Human (251.260) ESEDKPEIED 
Mouse (251.260) ESDDKPEIED 
Peptide 5 HIWITGETK 
Human (490-499) HIWITGETK 
Mouse (491-500) HIYFITGETK 
Peptide 2 YIDQEELNK 
Human (284-292) YIDQEELNK 
Mouse (285-293) YIDQEELNK 
Peptide 6 EGLYLPEDEEEK 
Human (547.556) EGLELPEDEEEK 
Mouse (546-559) EGLELPEDEEEK 
Peptide 3 SLTNDWEDXLAV 
Human (315.326) SLTNDWEDHLAV 
Mouse (316.327) SLTNDWEEHLAV 
[2] Tsubuki. S., Kawasaki, H., Saito, Y., Miyashita, N., Inomata, M. 
and Kawashima, S. (1993) Biochem. Biophys. Res. Commun. 196, 
1195-1201. 
Fig. 6. Amino acid sequence of the inhibitor and its homology to human [3] Matthews, W., Tanaka, K.. Driscoll, J., Ichihara, A. and Gold- 
HSP90 and murine HSP90. X, amino acid residues not identified. berg. A.L. (1989) Proc. Natl. Acad. Sci. USA 86, 2597-2601. 
Fig. 7. Immunological detection of the inhibitor by anti-rabbit HSP90 
polyclonal antibody. The immunogen of this antibody is the synthetic 
peptide of the N-terminal amino acids 2212 in murine HSP90. 
hormone receptors [32]. It is suggested that HSP90 plays 
several important roles in cells, one being to act as a 
chaperon. On the other hand, proteasome is the catalytic 
machinery in the ATP-dependent proteolytic system. In 
this system, some targeting mechanism as a mark for 
proteins to be degraded is necessary and the involvement 
of chaperons has been speculated. Ubiquitination by 
ubiquitin, a kind of stress protein, is the only chaperon 
integrated into the proteolytic system. Now another 
stress protein, HSP90, has joined as a new member of the 
system and is expected to regulate neurite outgrowth in 
the nervous system as follows. 
We began this work based on the fact that a cell- 
permeable protease inhibitor, ZLLLal, initiates neurite 
outgrowth in PC12 cells [l]. Next we purified proteasome 
as the target protease of ZLLLal and found a good 
correlation between neurite promotion activity and in- 
hibitory activity towards the ZLLL-MCA degrading ac- 
tivity in proteasome of a series of protease inhibitors [2]. 
If neurite outgrowth is induced by the inhibition of 
ZLLL-MCA degrading activity, as found for ZLLLal, 
then there should exist a physiological modulator of 
ZLLL-MCA degrading activity. We found HSP90 was 
the inhibitor. In fact, there is a report showing that when 
heat shock is applied to neuroblastoma cells, HSPs are 
synthesized and, at the same time, the development of 
neurites is induced after 3-6 days [33]. 
Although another endogenous protein that inhibits 
the substrate degrading activities in proteasome has been 
isolated, this endogenous inhibitor does not have cata- 
lytic site specificity [34]. For this reason, too, it is a very 
significant finding that HSP90 specifically inhibits the 
ZLLL-MCA degrading activity in proteasome. 
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